Evidence map›Paper›PMID 42788128›Full record

ArticleRSC advances2026

Engineering pectin- and sodium alginate-based nanoemulgels for topical delivery of

Bahruz S Mammadov, Sevil J Mehraliyeva, Rukiye Sevinc Özakar, Emrah Özakar, Yasin Bayır, A Alper Öztürk, Eldar Gasimov, Fuad Rzayev

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bahruz S MammadovAzerbaijan Medical University, Department of Pharmaceutical Technology and Management Baku AZ1022 Azerbaijan dr.mamedov_86@mail.ru prof.nanopharmacy@gmail.com.
Sevil J MehraliyevaAzerbaijan Medical University, Department of Pharmaceutical Technology and Management Baku AZ1022 Azerbaijan dr.mamedov_86@mail.ru prof.nanopharmacy@gmail.com.
Rukiye Sevinc ÖzakarAtatürk University, Faculty of Pharmacy, Department of Pharmaceutical Technology Erzurum 25240 Türkiye rukiyeso@atauni.edu.tr emrahozakar@atauni.edu.tr.
Emrah ÖzakarAtatürk University, Faculty of Pharmacy, Department of Pharmaceutical Technology Erzurum 25240 Türkiye rukiyeso@atauni.edu.tr emrahozakar@atauni.edu.tr.ORCID https://orcid.org/0000-0002-7443-208X
Yasin BayırAtatürk University, Faculty of Pharmacy, Department of Biochemistry Erzurum 25240 Türkiye ybayir@atauni.edu.tr.
A Alper ÖztürkAnadolu University, Department of Pharmaceutical Technology Tepebaşı Eskişehir 26470 Türkiye aaozturk@anadolu.edu.tr.
Eldar GasimovAzerbaijan Medical University, Department of Cytology, Embryology, and Histology Baku AZ1022 Azerbaijan eldar.gasimov@amu.edu.az.ORCID https://orcid.org/0000-0002-5104-4260
Fuad RzayevAzerbaijan Medical University, Department of Electron Microscopy of the Scientific Research Center Baku AZ1022 Azerbaijan fuad.rzayev@amu.edu.az.ORCID https://orcid.org/0000-0002-8128-1101

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in nanotechnology have enabled nanoscale topical delivery systems with controlled release and enhanced therapeutic performance. This study developed and evaluated a nanoemulgel incorporating

Identifiers

PMID42788128
PMCPMC13607956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.